Literature DB >> 29762835

MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.

X Lv1, C-Y Li, P Han, X-Y Xu.   

Abstract

OBJECTIVE: MicroRNAs are a class of small non-coding RNAs that be involved in the pathogenesis of non-small cell lung cancer (NSCLC). The purpose of this study was to evaluate the effects of miR-520a-3p in cell growth and metastasis.
MATERIALS AND METHODS: The mimics and inhibitor of miR-520a-3p were used to identify the effects of miR-520a-3p on cell proliferation and apoptosis using methylthiazol tetrazolium (MTT) assay and flow-cytometric method, respectively. Transwell assay was used to evaluate the cell migration and invasion. The protein expression levels related PI3K/AKT/mTOR signaling pathways were measured by Western blot.
RESULTS: The results showed that miR-520a-3p overexpression could significantly inhibit cell proliferation and induce apoptosis, suppress cell migration and invasion. MiR-520a-3p overexpression could markedly reduce the ratio of p-AKT/AKT, p-PI3K/PI3K and Bcl-2/Bax, the levels of mTOR, matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) compared with control. However, miR-520a-3p overexpression could increase caspase-3 expression compared with control group. After inhibited the expression of miR-520a-3p, the capacity of cell proliferation, migration and invasion were increased, cell apoptosis was inhibited compared with control group. The ratio of p-AKT/AKT, p-PI3K/PI3K and Bcl-2/Bax, the levels of mTOR, MMP-2 and MMP-9 were increased compared with control group.
CONCLUSIONS: Our study suggested that miR-520a-3p could suppress the NSCLC proliferation, migration and invasion through PI3K/AKT/mTOR signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762835     DOI: 10.26355/eurrev_201804_14822

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  18 in total

1.  Expression of miR-141 and YAP1 in gastric carcinoma and modulation of cancer cell proliferation and apoptosis.

Authors:  Fangchao Du; Chao Yu; Rui Li; Ding Ding; Lei He; Gang Wen
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

2.  miR-296-3p targets APEX1 to suppress cell migration and invasion of non-small-cell lung cancer.

Authors:  Lifeng Wang; Ruilin Chen; Yongqing Zhang
Journal:  Oncol Lett       Date:  2019-07-05       Impact factor: 2.967

3.  The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer.

Authors:  Xiang Fang; Huiying Shi; Fang Sun
Journal:  Clin Transl Oncol       Date:  2022-03-05       Impact factor: 3.340

4.  MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression.

Authors:  Jingwei Li; Wei Shao; Junhong Zhao
Journal:  Hum Cell       Date:  2020-11-16       Impact factor: 4.174

5.  The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer.

Authors:  Hui-Yu Lin; Chia-Hao Kuei; Hsun-Hua Lee; Che-Hsuan Lin; Jing-Quan Zheng; Hui-Wen Chiu; Chi-Long Chen; Yuan-Feng Lin
Journal:  Aging (Albany NY)       Date:  2020-07-01       Impact factor: 5.682

6.  Long noncoding RNA HOXA-AS2 promotes non-small cell lung cancer progression by regulating miR-520a-3p.

Authors:  Yunpeng Liu; Xingyu Lin; Shiyao Zhou; Peng Zhang; Guoguang Shao; Zhiguang Yang
Journal:  Biosci Rep       Date:  2019-05-31       Impact factor: 3.976

7.  miR520a-3p suppresses cell proliferation and metastasis by inhibiting the p65-NFκB pathway in glioblastoma.

Authors:  Jing-Quan Zhang; Bo Hong
Journal:  Onco Targets Ther       Date:  2019-08-14       Impact factor: 4.147

8.  Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p.

Authors:  Nianliang Zhang; Xiangji Xing; Fengcai Gu; Gang Zhou; Xianglan Liu; Baoqiang Li
Journal:  Onco Targets Ther       Date:  2020-06-09       Impact factor: 4.147

9.  LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.

Authors:  Jing Lin; Shasha Liao; Zewa Liu; E Li; Xiaohua Wu; Wanting Zeng
Journal:  Cancer Biol Ther       Date:  2021-04-02       Impact factor: 4.742

10.  IMPA2 Downregulation Enhances mTORC1 Activity and Restrains Autophagy Initiation in Metastatic Clear Cell Renal Cell Carcinoma.

Authors:  Chia-Hao Kuei; Hui-Yu Lin; Hsun-Hua Lee; Che-Hsuan Lin; Jing-Quan Zheng; Kuan-Chou Chen; Yuan-Feng Lin
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.